Author:
Fenton Caroline,Kang Connie
Publisher
Springer Science and Business Media LLC
Reference35 articles.
1. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: 2020. Bethesda: Global Initiative for Chronic Obstructive Lung Disease (GOLD); 2020.
2. Currow DC, Agar MR. Benzodiazepine prescribing in people with chronic obstructive pulmonary disease: clinical considerations. Drugs Aging. 2020;37(4):263–70.
3. Ford ES, Wheaton AG. Trends in outpatient visits with benzodiazepines among US adults with and without bronchitis or chronic obstructive pulmonary disease from 1999 to 2010. COPD. 2015;12(6):649–57.
4. Tu K, Mamdani MM, Hux JE, et al. Progressive trends in the prevalence of benzodiazepine prescribing in older people in Ontario, Canada. J Am Geriatr Soc. 2001;49(10):1341–5.
5. Uhlenhuth EH, Balter MB, Ban TA, et al. International study of expert judgment on therapeutic use of benzodiazepines and other psychotherapeutic medications: IV. Therapeutic dose dependence and abuse liability of benzodiazepines in the long-term treatment of anxiety disorders. J Clin Psychopharmacol. 1999;19(6):23S-9S.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Ethanolic extract of Lannea coromandelica stem bark;Journal of Advanced Pharmaceutical Technology & Research;2022-10